SCHEMBL8212451

SCHEMBL8212451

[CH2]CCCCC(=O)N1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 4/20 0.49
GNAI1 P63096 4/20 0.49
GNAO1 P09471 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
ATM Q13315 1/20 0.47
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 2/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6043670 0.94 ATM (0.48) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL1711871 0.86 TDP1 (0.48) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL4548026 0.82 L3MBTL1 (0.71) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL12923889 0.82 PAOX (0.61) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL6043600 0.82 GNAI3 (0.50) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL6043595 0.82 GNAI3 (0.50) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL4686342 0.82 ATM (0.71) L3MBTL1KMT2AMEN1TDP1ATM
SCHEMBL294495 0.81 L3MBTL1 (0.54) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL8972852 0.81 GNAI3 (0.71) GNAI3GNAI1GNAO1L3MBTL1KMT2A
SCHEMBL14520784 0.81 KMT2A (0.57) GNAI3GNAI1GNAO1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100262-A MORPHOLINE RING NITROGEN IS SUBSTITUTED WITH A GROUP HAIVNG A CARBONYL FUNCTIONALITY; FAVOURABLE GASTROINTESTINAL MOTILITY STIMULATING PROPERTIES, THEY ACCELERATE GASTRIC EMPTYING JANSSEN PHARMACEUTICA, NV. (BE) 2000-08-08 US disclosed
EP-0827500-A1 (2-MORPHOLINYLMETHYL)BENZAMIDE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1998-03-11 EP disclosed
WO-1996037486-A1 (2-MORPHOLINYLMETHYL)BENZAMIDE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1996-11-28 WO disclosed